Cogent Biosciences, Inc.
COGT
$34.29
-$0.24-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 252.67% | 213.77% | 16.50% | -34.52% | -43.62% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.18% | 2.08% | 5.74% | 6.00% | 17.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 247.12% | 207.06% | 16.31% | -33.78% | -42.77% |
|
|
|||||
| Total Current Assets | 247.12% | 207.06% | 16.31% | -33.78% | -42.77% |
| Net Property, Plant & Equipment | -12.30% | -11.40% | -13.52% | -12.20% | -11.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -51.54% | -23.55% | -0.78% | 0.00% | 0.00% |
| Total Assets | 218.19% | 185.94% | 10.92% | -36.08% | -40.39% |
|
|
|||||
| Total Accounts Payable | -2.90% | -20.89% | 6.43% | 85.24% | -9.07% |
| Total Accrued Expenses | 24.01% | 10.53% | 19.54% | 32.64% | 73.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.15% | -1.15% | 12.24% | 12.41% | 12.50% |
| Total Finance Division Other Current Liabilities | 281.40% | 1,708.31% | 319.93% | 405.16% | -23.90% |
| Total Other Current Liabilities | 281.40% | 1,708.31% | 319.93% | 405.16% | -23.90% |
| Total Current Liabilities | 17.57% | 14.80% | 17.34% | 46.04% | 34.43% |
|
|
|||||
| Total Current Liabilities | 17.57% | 14.80% | 17.34% | 46.04% | 34.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.93% | -9.73% | -10.46% | -9.92% | -9.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,140.00% | -- | -- | -- | -- |
| Total Liabilities | 355.71% | 320.65% | 78.02% | 111.21% | 20.50% |
|
|
|||||
| Common Stock & APIC | 75.52% | 72.69% | 28.71% | 7.33% | 20.87% |
| Retained Earnings | -38.04% | -38.27% | -37.19% | -39.40% | -40.71% |
| Treasury Stock & Other | -353.05% | -20.58% | -76.79% | 106.77% | 520.51% |
| Total Common Equity | 389.89% | 275.45% | -4.66% | -81.81% | -44.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -40.13% | -19.17% | -2.43% | -5.44% | -51.31% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -40.13% | -19.17% | -2.43% | -5.44% | -51.31% |
|
|
|||||
| Total Common Equity | 389.89% | 275.45% | -4.66% | -81.81% | -44.64% |
| Total Preferred Equity | -40.13% | -19.17% | -2.43% | -5.44% | -51.31% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 177.49% | 148.31% | -3.88% | -58.46% | -48.15% |
|
|
|||||